Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
Forbes
Mon, 10/16/23 - 10:13 am
Tags:
Pfizer, BioNTech, Moderna Therapeutics, vaccines, COVID-19
Pfizer to cut costs, lay off staff on waning demand for COVID products
BioPharma Dive
Sat, 10/14/23 - 12:08 pm
Tags:
Pfizer, layoffs, COVID-19
Pfizer takes aim at BMS' first-in-class Zeposia with FDA nod for ulcerative colitis drug Velsipity
Fierce Pharma
Fri, 10/13/23 - 10:35 am
Tags:
Bristol Myers Squibb, Zeposia, Pfizer, Velsipity, etrasimod, ulcerative colitis, FDA
FDA finds no misconduct at trial sites for Pfizer's Lyme disease shot, Care Access says
Reuters
Thu, 10/12/23 - 11:36 am
Tags:
Pfizer, clinical trials, Lyme disease, Valneva, vaccines, FDA
Pfizer, playing catch-up with Novartis, bags FDA approval for drug combo in lung cancer
Fierce Pharma
Thu, 10/12/23 - 11:34 am
Tags:
Pfizer, Braftovi, Maktovi, metastatic non-small cell lung cancer, FDA
Widespread use of Pfizer's maternal RSV shot would reduce costs and prevent infant hospitalizations: study
Fierce Pharma
Wed, 10/11/23 - 11:52 pm
Tags:
Pfizer, RSV, vaccines, pregnancy, infants
Pfizer inks another EpiPen antitrust settlement, this one worth $50
Fierce Pharma
Wed, 10/11/23 - 11:48 pm
Tags:
Pfizer, EpiPen, antitrust, class action lawsuits
FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
Generics Bulletin
Mon, 10/9/23 - 11:34 pm
Tags:
Pfizer, Humira, biosimilars, adalimumab, AbbVie, interchangeability, FDA
Pfizer resolves Promosome patent lawsuit over COVID-19 vaccine
Reuters
Fri, 10/6/23 - 10:03 am
Tags:
Pfizer, BioNTech, Promosome, legal, vaccines, MRNA, COVID-19
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
Tags:
FDA, Alnylam, Onpattro, ATTR amyloidosis, Vertex Pharmaceuticals, CRISPR Therapeutics, exa-cel, Bluebird Bio, Zynteglo, sickle cell disease, Bristol Myers Squibb, 2seventy bio, Abecma, Multiple Myeloma, Amgen, Lumakras, non-small cell lung cancer, Pfizer, estrasimod, ulcerative colitis
Why Pfizer and BioNTech Stocks Zoomed Higher Friday
Motley Fool
Sun, 10/1/23 - 01:06 pm
Tags:
COVID-19, vaccines, Pfizer, BioNTech
Where Will Pfizer Be in 5 Years?
Motley Fool
Fri, 09/29/23 - 10:09 am
Tags:
Pfizer, COVID-19, Seagen
Patient Death Likely from Virus Used to Deliver Gene-Editing Therapy: NEJM Study
BioSpace
Thu, 09/28/23 - 10:33 am
Tags:
NEJM, clinical trials, Duchenne Muscular Dystrophy, patient deaths, Astellas, Pfizer
Pfizer hooks up with Ginkgo for $331M biobucks deal on unspecified targets
Fierce Biotech
Wed, 09/27/23 - 10:07 am
Tags:
Ginkgo Bioworks, Pfizer, drug discovery, RNA
Pfizer restarts production at tornado-hit plant—but supply squeezes are expected to persist
Fierce Pharma
Mon, 09/25/23 - 07:41 pm
Tags:
Pfizer, North Carolina, tornado, drug manufacturing, drug shortages
CDC recommends RSV vaccine in late pregnancy to protect newborns
NPR
Sun, 09/24/23 - 08:53 pm
Tags:
Pfizer, CDC, pregnancy, RSV, Abryvso, vaccines
Covid Drug Paxlovid Now Less Effective Than In Early Trials—But It’s Still Great At Preventing Death
Forbes
Fri, 09/22/23 - 11:58 am
Tags:
Pfizer, Paxlovid, clinical trials, COVID-19
Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts
Fierce Pharma
Mon, 09/18/23 - 08:01 pm
Tags:
Pfizer, BridgeBio, Alnylam, FDA, clinical trials, ATTR-CM, physicians, tafamidis
Pfizer forecasts 24% COVID vaccination rate in US this year
Yahoo/Reuters
Mon, 09/18/23 - 10:00 am
Tags:
Pfizer, vaccines, COVID-19
EU clears review of Xtandi in earlier-stage prostate cancer
Pharmaphorum
Wed, 09/13/23 - 06:02 pm
Tags:
EMA, Europe, Astellas, Pfizer, prostate cancer, Xtandi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.